Helicobacter pylori: Its discovery and relevance for medicine;Helicobacter pylori: Su descubrimiento e importancia en la medicina

Revista Espanola de Enfermedades Digestivas

Volumn 98, Issue 10, 2006, Pages 770-785

  Pajares García, José María ^a   Gisbert, J P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Discovery; Duodenal ulcer; Gastric ulcer; Gastritis; Helicobacter pylori; Nobel 2005; Peptic ulcer

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; BISMUTH SALT; CIMETIDINE; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RADIOISOTOPE; TETRACYCLINE; UREASE;

BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CAMPYLOBACTER; CAUSAL ATTRIBUTION; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG POTENCY; DRUG SUBSTITUTION; ENZYME BLOOD LEVEL; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INOCULATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDICAL SOCIETY; NONHUMAN; PEPTIC ULCER; REVIEW; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH EPITHELIUM; STOMACH LYMPHOMA; ARTICLE; GASTROENTEROLOGY; HISTORY;

BIOMEDICAL RESEARCH; GASTROENTEROLOGY; HELICOBACTER PYLORI; HISTORY, 20TH CENTURY; HUMANS;

EID: 34547845390     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Press Release. The 2005 Nobel Prize in Physiology or Medicine. 3rd October 2005. Available at: http://www.nobelprize.org
2. Warren JR. The discovery of Helicobacter pylori in Perth, Western Australia. In: Marshall B, editor. Helicobacter Pioneers (Firsthand account from the scientists who discovered helicobacters. 1892-1982). Blackwell Science Asia; 2002. p. 151-64.
3. Allen Pin. What's the story H. pylori? (Feature). Lancet 2001; 1: 694.
4. Fung WP, Papadimitriu JM, Matz LR. Endoscopic, histological and ultrastructural correlations in chronic gastritis. Am J Gastroenterol 1979; 71: 269-79.
5. Marshall BJ. The discovery that Helicobacter pylori, a spiral bacterium, caused peptic ulcer disease. In: Marshall B, editor. Helicobacter Pioneers (Firsthand account from the scientists who discovered helicobacters. 1892-1982). Blackwell Science Asia; 2002. p. 165-202.
6. Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DE, Miller JP. Differences in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1981; 1: 7-10.
7. Gregory MA, Moshal MG, Spitaels JM. The effect of tri-potassium di-citrato bismuthate on the duodenal mucosa during ulceration. An ultrastructural study. S Afr Med J 1982; 62: 52-5.
8. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
9. McNulty CA, Watson DM. Spiral bacteria of the gastric antrum. Lancet 1984; 1: 1068-9.
10. Langenberg W, Tytgat GN, Shipper ME, et al. Campylobacter-like organism in the stomach of patients and healthy individuals. Lancet 1984; 1: 1348-9.
11. Eldridge J, Lessels AM, Jones DM. Antibody to spiral organisms on gastric mucosa. Lancet 1984; 1: 1237.
12. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436-9.
13. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273.
14. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-4.
15. Jones DM, Curry A, Fox AJ. An ultrastructural study of the gastric Campylobacter-like organism "Campylobacter pyloridis". J Gen Microbiol 1985; 131: 2335-41.
16. Davis CP, Cleven D, Brown J, et al. Anaerobiospirillum, a new genus of spiral-shaped bacteria. Int J Syst Bacteriol 1976; 26: 498-504.
17. Beji A, Megraud F, Vincent P, Gavini F, Izard D, Leclerc H. GC content of DNA of Campylobacter pylori and other species belonging to the genus Campylobacter. Ann Inst Pasateur/Microbiol 1988; 138: 527-34.
18. Thompson LM, Smibert RM, Johnson JL, et al. Phylogenic study of the genus Campylobacter. In J Syst Bact 1988; 38: 109-200.
19. Lambert MA, Patton CM, Barrett TJ, Moss CW. Differentiation of Campylobacter and Campylobacter-like organisms by cellular fatty acid composition. J Clin Microbiol 1987; 25: 706-13.
20. Hazell SL. Microbiology and taxonomy of Helicobacter pylori and related bacteria. In: Marshall BJ, McCallum R, Guerrant RL, editors. Helicobacter pylori in peptic ulceration and gastritis. Boston: Blackwell Scientific Publications; 1991. p. 19-34.
21. Goodwin CS, Armstrong JA, Chilvers T, et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen.nov.as Helicobacter pylori comb.nov. and Helicobacter mustelae comb.nov., respectively. Int J Syst Bacteriol 1989; 39: 397-405.
22. Johnston BJ, Reed PI, Ali MH. Campylobacter-like organisms in duodenal and antral endoscopic biopsies: Relationship to inflammation. Gut 1986; 27: 1132-7.
23. Jiang SJ, Liu WZ, Zhang DZ, Shi Y, Xiao SD, Zhang ZH, et al. Campylobacter-like organisms in chronic gastritis, peptic ulcer, and gastric carcinoma. Scand J Gastroentrol 1987; 22: 553-8.
24. Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, et al. Campylobacter pylori and recurrence of duodenal ulcers - a 12 month follow-up study. Lancet 1987; 2: 1109-10.
25. Raws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of H. pylori. Lancet 1990; 335: 1233.
26. Wyatt JI, Rathbone BJ, Dixon MF, Haetley RV. Campylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841-8.
27. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumor necrosis factor alpha and interleukin-6- in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
28. Moss SF, Legon S, Bishop AE, Plak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-2.
29. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. New Eng J Med 1991; 325: 1127-31.
30. Nomura A, Stemmermann GN, Chyou PH, Kato I, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japonese Americans in Hawaii. New Eng J Med 1991; 325: 1132-6.
31. IARC. Monographs on the evaluation of the Carcinogenic risks to human. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer; 1994.
32. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori induces gastric cancer in monogolian gerbils. Gastroenterology 1998; 115: 642-8.
33. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-6.
34. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B cell lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
35. Graham DY, Klein PD, Evans DJ Jr, Evans DG, Alpert DC, Opekun AR, et al. Campylobacter pylori detected non-invasively by the 13C-urea breath test. Lancet 1987; 1: 1174-7.
36. Monés J, Gisbert JP, Bordá F, Domínguez Muñoz E y "Grupo Conferencia Española de Consenso". Indications, diagnostic methods, and eradication treatment of Helicobacter pylori. Recommendations of the second Spanish Consensus Conference. Rev Esp Enferm Dig 2005; 97: 348-74.
37. Gisbert JP, Calvet X, Gomollón F, Monés J y "Grupo Conferencia Española de Consenso sobre Helicobacter pylori". Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Española de consenso. Med Clin (Barc) 2005; 125: 301-16.
38. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease: NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65-9.
39. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
40. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
41. Working Party of the European Helicobacter pylori Study Group. Guidelines for clinical trials in H. pylori infection. Gut 1997; 41 (Supl. 2): S1-9.